gMed and Miraca Life Sciences Announce Partnership
Weston, FL (April 3, 2013) – gMed and Miraca Life Sciences are excited to announce a renewed partnership combining the best GI technology and the best Anatomic Pathology to create a product suite focused on delivering exceptional quality and support for our joint clients. Combining both organizations’ capabilities will bring increased efficiencies and streamlined processes to a demanding specialty market.
“Miraca Life Sciences is delighted that we can enhance our relationship with gMed through this strategic alliance,” stated Frank Basile, M.D., President and CEO for Miraca. “Our combined strengths will deliver a compelling and relevant value proposition to our clients as they strive to provide excellent care to their patients and meet the demands of the marketplace. Miraca Life Sciences looks forward to a successful and growing collaboration with gMed in the coming months and years.”
The partnership between Miraca and gMed was initiated several years ago and was renewed via strategic alignment and increased marketplace needs. Both companies are looking forward to working together to provide the best solutions for Gastroenterology practices nationwide.
“The ability to provide specialty specific products with the required interoperability and automation continues to be paramount at gMed,” stated Joe Rubinsztain, MD and CEO of gMed. “Miraca and gMed are committed to helping physicians drive optimal decisions using the most up-to-date information, leading to better patient outcomes.”
Miraca Life Sciences specializes in the development and commercialization of the highest quality anatomic pathology services, primarily in the fields of dermatology, hematology, gastroenterology and urology. The company’s core team of more than 70 academic-caliber specialists utilizes state of the art pathology laboratories currently headquartered in Irving, Texas, and throughout the United States to serve more than 3,000 patients every day. Through rigorous quality assurance, daily and monthly conferences, and close relationships with clinical partners, Miraca Life Sciences continuously improves diagnostic precision.